177 related articles for article (PubMed ID: 37259331)
1. Antitumor Activity of Bioactive Compounds from
Petrova M; Vlahova Z; Schröder M; Todorova J; Tzintzarov A; Gospodinov A; Velkova L; Kaynarov D; Dolashki A; Dolashka P; Ugrinova I
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259331
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial Action of Protein Fraction Isolated from
Kirilova M; Topalova Y; Velkova L; Dolashki A; Kaynarov D; Daskalova E; Zheleva N
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256901
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate moieties of molluscan Rapana venosa hemocyanin.
Dolashka-Angelova P; Beck A; Dolashki A; Stevanovic S; Beltramini M; Salvato B; Hristova R; Velkova L; Voelter W
Micron; 2004; 35(1-2):101-4. PubMed ID: 15036306
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the carbohydrate moieties of the functional unit RvH1-a of Rapana venosa haemocyanin using HPLC/electrospray ionization MS and glycosidase digestion.
Dolashka-Angelova P; Beck A; Dolashki A; Beltramini M; Stevanovic S; Salvato B; Voelter W
Biochem J; 2003 Aug; 374(Pt 1):185-92. PubMed ID: 12732096
[TBL] [Abstract][Full Text] [Related]
5. Glycan structures and antiviral effect of the structural subunit RvH2 of Rapana hemocyanin.
Dolashka P; Velkova L; Shishkov S; Kostova K; Dolashki A; Dimitrov I; Atanasov B; Devreese B; Voelter W; Van Beeumen J
Carbohydr Res; 2010 Nov; 345(16):2361-7. PubMed ID: 20863484
[TBL] [Abstract][Full Text] [Related]
6. Hemocyanins from
Georgieva A; Todorova K; Iliev I; Dilcheva V; Vladov I; Petkova S; Toshkova R; Velkova L; Dolashki A; Dolashka P
Biomedicines; 2020 Jul; 8(7):. PubMed ID: 32635655
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis and molecular modeling of the RvH2-e functional unit of Rapana venosa hemocyanin.
Velkova L; Dolashka P; Dolashki A; Voelter W; Atanasov B
Biochim Biophys Acta; 2010 Dec; 1804(12):2177-82. PubMed ID: 20807592
[TBL] [Abstract][Full Text] [Related]
8. Oligomeric stability of Rapana venosa hemocyanin (RvH) and its structural subunits.
Dolashka-Angelova P; Schwarz H; Dolashki A; Stevanovic S; Fecker M; Saeed M; Voelter W
Biochim Biophys Acta; 2003 Mar; 1646(1-2):77-85. PubMed ID: 12637014
[TBL] [Abstract][Full Text] [Related]
9. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
10.
Boyanova O; Dolashka P; Toncheva D; Rammensee HG; Stevanović S
Biomed Rep; 2013 Mar; 1(2):235-238. PubMed ID: 24648926
[TBL] [Abstract][Full Text] [Related]
11. o-Diphenol oxidase activity of molluscan hemocyanins.
Hristova R; Dolashki A; Voelter W; Stevanovic S; Dolashka-Angelova P
Comp Biochem Physiol B Biochem Mol Biol; 2008 Mar; 149(3):439-46. PubMed ID: 18162195
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines.
Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D
Int J Oncol; 2013 Apr; 42(4):1263-70. PubMed ID: 23403907
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Activity of Molluscan Hemocyanins from Helix and Rapana Snails.
Dolashka P; Dolashki A; Van Beeumen J; Floetenmeyer M; Velkova L; Stevanovic S; Voelter W
Curr Pharm Biotechnol; 2016; 17(3):263-70. PubMed ID: 26343131
[TBL] [Abstract][Full Text] [Related]
14. The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: An In Vitro and In Vivo Comparison Study with Herceptin.
Lai HW; Chien SY; Kuo SJ; Tseng LM; Lin HY; Chi CW; Chen DR
Evid Based Complement Alternat Med; 2012; 2012():486568. PubMed ID: 21876713
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anticancer effects of a bioactive subfraction of Strobilanthes crispus and tamoxifen on MCF-7 and MDA-MB-231 human breast cancer cell lines.
Yaacob NS; Kamal NN; Norazmi MN
BMC Complement Altern Med; 2014 Jul; 14():252. PubMed ID: 25034326
[TBL] [Abstract][Full Text] [Related]
16. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
[TBL] [Abstract][Full Text] [Related]
17. Reversibility and "pH-T phase diagrams" of Rapana venosa hemocyanin and its structural subunits.
Dolashki A; Velkova L; Atanasov B; Voelter W; Stevanovic S; Schwarz H; Di Muro P; Dolashka-Angelova P
Biochim Biophys Acta; 2008 Nov; 1784(11):1617-24. PubMed ID: 18602502
[TBL] [Abstract][Full Text] [Related]
18. A challenging insight on the structural unit 1 of molluscan Rapana venosa hemocyanin.
Dolashka-Angelova P; Stevanovic S; Dolashki A; Devreese B; Tzvetkova B; Voelter W; Van Beeumen J; Salvato B
Arch Biochem Biophys; 2007 Mar; 459(1):50-8. PubMed ID: 17291443
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
Lindner DJ; Borden EC
J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
[TBL] [Abstract][Full Text] [Related]
20. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
